{{Rsnum
|rsid=4500751
|Gene=NTAN1
|Chromosome=16
|position=15046354
|Orientation=plus
|GMAF=0.3186
|Gene_s=NTAN1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 48.7 | 44.2 | 7.1
| HCB | 42.3 | 40.9 | 16.8
| JPT | 37.2 | 53.1 | 9.7
| YRI | 74.1 | 23.8 | 2.0
| ASW | 61.4 | 26.3 | 12.3
| CHB | 42.3 | 40.9 | 16.8
| CHD | 39.4 | 45.0 | 15.6
| GIH | 27.7 | 46.5 | 25.7
| LWK | 68.2 | 30.0 | 1.8
| MEX | 22.4 | 48.3 | 29.3
| MKK | 64.1 | 31.4 | 4.5
| TSI | 42.2 | 47.1 | 10.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22359512
|Trait=None
|Title=Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations.
|RiskAllele=
|Pval=6E-23
|OR=0
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}